Cargando…
BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma
Pleomorphic xanthoastrocytomas can be very resistant to treatment if they progress after standard therapy with surgery and radiation. We present the case of a patient with a multiply recurrent pleomorphic xanthoastrocytoma which demonstrated a sustained partial response to a combination regimen of t...
Autores principales: | Lukas, Rimas V, Merrell, Ryan T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977279/ https://www.ncbi.nlm.nih.gov/pubmed/29708404 http://dx.doi.org/10.2217/cns-2017-0032 |
Ejemplares similares
-
Pleomorphic xanthoastrocytoma: a brief review
por: Shaikh, Nawal, et al.
Publicado: (2019) -
Clinical outcomes for pleomorphic xanthoastrocytoma patients: an institutional experience
por: Sullivan, Jared, et al.
Publicado: (2023) -
BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma
por: Migliorini, Denis, et al.
Publicado: (2017) -
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
por: Dias-Santagata, Dora, et al.
Publicado: (2011) -
A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
por: Hsiao, Susan J., et al.
Publicado: (2017)